US Stock MarketDetailed Quotes

BNTC Benitec Biopharma

Watchlist
  • 12.0000
  • 0.00000.00%
Close Dec 27 16:00 ET
  • 12.0000
  • 0.00000.00%
Post 20:01 ET
278.60MMarket Cap-4.08P/E (TTM)

Benitec Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
0
0
0
0
0
0
2.74%75K
7K
12.50%54K
-44.00%14K
Operating revenue
--0
--0
--0
--0
--0
--0
2.74%75K
--7K
12.50%54K
-44.00%14K
Cost of revenue
1K
0
Gross profit
-107.14%-1K
14K
Operating expense
-1.41%5.79M
17.40%22.49M
21.75%5.55M
-5.78%4.14M
23.15%6.93M
28.25%5.87M
6.91%19.16M
-3.64%4.56M
25.29%4.4M
15.72%5.62M
Selling and administrative expenses
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
8.69%1.86M
-General and administrative expense
42.23%2.21M
9.51%6.99M
48.50%2.04M
28.50%1.58M
-2.09%1.82M
-19.22%1.55M
-3.97%6.38M
-11.72%1.37M
-8.15%1.23M
8.69%1.86M
Research and development costs
-19.06%3.59M
22.19%15.61M
10.23%3.51M
-18.98%2.57M
35.66%5.1M
66.50%4.43M
13.33%12.77M
0.31%3.19M
45.88%3.17M
19.55%3.76M
Other operating expenses
----
---108K
--0
---3K
----
---106K
----
----
----
----
Operating profit
1.41%-5.79M
-17.87%-22.49M
-21.93%-5.55M
4.61%-4.14M
-23.48%-6.93M
-28.25%-5.87M
-6.87%-19.08M
3.97%-4.55M
-25.46%-4.34M
-16.03%-5.61M
Net non-operating interest income expense
10,166.67%604K
2,839.39%904K
11,600.00%920K
42.86%-4K
33.33%-6K
33.33%-6K
-3.13%-33K
20.00%-8K
30.00%-7K
18.18%-9K
Non-operating interest expense
----
----
----
-42.86%4K
-33.33%6K
----
----
----
-30.00%7K
-18.18%9K
Total other finance cost
-10,166.67%-604K
-2,839.39%-904K
----
----
----
--6K
--33K
----
----
----
Other net income (expense)
272.97%128K
63.17%-165K
10.68%-92K
-173.47%-134K
-35.10%135K
85.32%-74K
-39.13%-448K
67.71%-103K
-125.13%-49K
732.00%208K
Gain on sale of security
266.07%93K
109.33%39K
369.57%62K
-140.82%-118K
-4.43%151K
88.89%-56K
-72.02%-418K
91.45%-23K
-121.88%-49K
532.00%158K
Other non- operating income (expenses)
294.44%35K
-580.00%-204K
-92.50%-154K
---16K
-132.00%-16K
---18K
62.03%-30K
-60.00%-80K
----
--50K
Income before tax
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
Income tax
Net income
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
Net income continuous Operations
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
Minority interest income
Net income attributable to the parent company
15.03%-5.06M
-11.19%-21.75M
-1.27%-4.72M
2.68%-4.28M
-25.63%-6.8M
-16.91%-5.95M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
Preferred stock dividends
Other preferred stock dividends
0
619K
619K
0
Net income attributable to common stockholders
23.03%-5.06M
-14.35%-22.37M
-14.55%-5.34M
2.68%-4.28M
-25.63%-6.8M
-29.06%-6.57M
-7.44%-19.56M
8.01%-4.66M
-34.26%-4.4M
-12.24%-5.41M
Basic earnings per share
84.26%-0.48
60.98%-5.51
80.02%-0.5293
38.58%-1.64
20.96%-2.64
61.78%-3.05
62.72%-14.12
74.79%-2.65
60.74%-2.67
66.70%-3.34
Diluted earnings per share
84.26%-0.48
60.98%-5.51
80.02%-0.5293
38.58%-1.64
20.96%-2.64
61.78%-3.05
62.72%-14.12
74.79%-2.65
60.74%-2.67
66.70%-3.34
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue 0000002.74%75K7K12.50%54K-44.00%14K
Operating revenue --0--0--0--0--0--02.74%75K--7K12.50%54K-44.00%14K
Cost of revenue 1K0
Gross profit -107.14%-1K14K
Operating expense -1.41%5.79M17.40%22.49M21.75%5.55M-5.78%4.14M23.15%6.93M28.25%5.87M6.91%19.16M-3.64%4.56M25.29%4.4M15.72%5.62M
Selling and administrative expenses 42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M8.69%1.86M
-General and administrative expense 42.23%2.21M9.51%6.99M48.50%2.04M28.50%1.58M-2.09%1.82M-19.22%1.55M-3.97%6.38M-11.72%1.37M-8.15%1.23M8.69%1.86M
Research and development costs -19.06%3.59M22.19%15.61M10.23%3.51M-18.98%2.57M35.66%5.1M66.50%4.43M13.33%12.77M0.31%3.19M45.88%3.17M19.55%3.76M
Other operating expenses -------108K--0---3K-------106K----------------
Operating profit 1.41%-5.79M-17.87%-22.49M-21.93%-5.55M4.61%-4.14M-23.48%-6.93M-28.25%-5.87M-6.87%-19.08M3.97%-4.55M-25.46%-4.34M-16.03%-5.61M
Net non-operating interest income expense 10,166.67%604K2,839.39%904K11,600.00%920K42.86%-4K33.33%-6K33.33%-6K-3.13%-33K20.00%-8K30.00%-7K18.18%-9K
Non-operating interest expense -------------42.86%4K-33.33%6K-------------30.00%7K-18.18%9K
Total other finance cost -10,166.67%-604K-2,839.39%-904K--------------6K--33K------------
Other net income (expense) 272.97%128K63.17%-165K10.68%-92K-173.47%-134K-35.10%135K85.32%-74K-39.13%-448K67.71%-103K-125.13%-49K732.00%208K
Gain on sale of security 266.07%93K109.33%39K369.57%62K-140.82%-118K-4.43%151K88.89%-56K-72.02%-418K91.45%-23K-121.88%-49K532.00%158K
Other non- operating income (expenses) 294.44%35K-580.00%-204K-92.50%-154K---16K-132.00%-16K---18K62.03%-30K-60.00%-80K------50K
Income before tax 15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M
Income tax
Net income 15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M
Net income continuous Operations 15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M
Minority interest income
Net income attributable to the parent company 15.03%-5.06M-11.19%-21.75M-1.27%-4.72M2.68%-4.28M-25.63%-6.8M-16.91%-5.95M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M
Preferred stock dividends
Other preferred stock dividends 0619K619K0
Net income attributable to common stockholders 23.03%-5.06M-14.35%-22.37M-14.55%-5.34M2.68%-4.28M-25.63%-6.8M-29.06%-6.57M-7.44%-19.56M8.01%-4.66M-34.26%-4.4M-12.24%-5.41M
Basic earnings per share 84.26%-0.4860.98%-5.5180.02%-0.529338.58%-1.6420.96%-2.6461.78%-3.0562.72%-14.1274.79%-2.6560.74%-2.6766.70%-3.34
Diluted earnings per share 84.26%-0.4860.98%-5.5180.02%-0.529338.58%-1.6420.96%-2.6461.78%-3.0562.72%-14.1274.79%-2.6560.74%-2.6766.70%-3.34
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+0.58%
Halozyme Therapeutics
HALO
+0.21%
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
0.00%
YETI Holdings
YETI
-0.08%
Dorian LPG
LPG
-0.25%

Unlock the Full List